参考文献/References:
［1］ Nishio S, Kosuga K, Igaki K, et al. Long- Term（>10 years） clinical outcomes of first- in- human biodegradable poly- l- lactic acid coro- nary stents: Igaki- Tamai stents［J］. Circulation, 2012, 125: 2343- 2353.
［2］ Garg S, Serruys PW. Coronary stents: looking forward［J］. J Am Coll Cardiol, 2010, 56: S43- S78.
［3］ Verheye S, Ormiston JA, Stewart J, et al. A next- generation biore-
sorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12- month clinical and multimodality imaging results［J］. JACC Cardiovasc Interv, 2014, 7: 89- 99.
［4］ Heublein B, Rohde R, Kaese V, et al. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?［J］. Heart, 2003, 89: 651- 656.
［5］ Waksman R, Pakala R, Kuchulakanti PK, et al. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries［J］. Catheter Cardiovasc Interv, 2006, 68: 607- 617.
［6］ Haude M, Erbel R, Erne P, et al. Safety and performance of the drug- eluting absorbable metal scaffold（DREAMS） in patients with de- novo coronary lesions: 12 month results of the prospective, multicentre, first- in- man BIOSOLVE- I trial［J］. Lancet, 2013, 381: 836- 844.
［7］ Sing NB, Mostavan A, Hamzah E, et al. Degradation behavior of biodegradable Fe35Mn alloy stents［J］. J Biomed Mater Res B Appl Biomater, 2015, 103: 572- 577.
［8］ Lipinski MJ, Escarcega RO, Lhermusier T, et al. The effects of novel, bioresorbable scaffolds on coronary vascular pathophysiology［J］. J Cardiovasc Transl Res, 2014, 7: 413- 425.
［9］ Pollman MJ. Engineering a bioresorbable stent: REVA programme update［J］. EuroIntervention, 2009, 5: F54- F57.
［10］ Ormiston JA, Serruys PW, Regar E, et al. A bioabsorbable everolimu- seluting coronary stent system for patients with single de- novo coronary artery lesions （ABSORB）: a prospective open- label trial［J］. Lancet, 2008, 371: 899- 907.
［11］ Serruys PW, Ormiston JA, Onuma Y, et al. A bioabsorbable evero- limus- eluting coronary stent system（ABSORB）: 2- year outcomes and results from multiple imaging methods［J］. Lancet, 2009, 373: 897- 910.
［12］ Nakatani S, Onuma Y, Ishibashi Y, et al. Early （before 6 months）, late （6-12 months） and very late （after 12 months） angiographic scaffold restenosis in the ABSORB Cohort B trial［J］. EuroIn- tervention, 2015, 10: 1288- 1298.
［13］ Diletti R, Farooq V, Girasis C, et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSO［J］. Heart, 2013, 99: 98- 105.
［14］ Abizaid A, Ribamar Costa J, Bartorelli AL, et al. The ABSORB EXTEND study: preliminary report of the twelve- month clinical outcomes in the first 512 patients enrolled［J］. EuroIntervention, 2015, 10: 1396- 1401.
［15］ Mattesini A, Secco GG, Dall’ara G, et al. ABSORB biodegradable stents versus second- generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance［J］. JACC Cardiovasc Interv, 2014, 7: 741- 750.
［16］ Verheye S, Webster M, Stewart J, et al. TCT- 563: Multicenter, first- in- man evaluation of the myolimus- eluting bioresorbable coronary scaffold: 6- month clinical and imaging results［J］. J Am Coll Cardiol, 2012, 60: B163.
［17］ Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents : a pros- pective, non- randomised multicentre trial［J］. Lancet, 2007, 369: 1869- 1875.
［18］ Iqbal J, Onuma Y, Ormiston J, et al. Bioresorbable scaffolds: rationale, current status, challenges, and future［J］. Eur Heart J, 2014, 35: 765- 776.
［19］ 陈 华， 赵仙先． 生物可降解镁合金支架研究现状［J］． 介入放射学杂志， 2011， 20： 62- 64．
相似文献/References:
[1]王昌明,李 选,宋世兵,等.肝门部胆道引流管折叠技术在肝移植后胆道非吻合口狭窄治疗中的应用[J].介入放射学杂志,2012,(02):136.
WANG Chang-ming,LI Xuan,SONG Shi-bing,et al.The application of biliary catheter folding technique in the treatment of hilar nonanastomotic biliary strictures after orthotopic liver transplantation[J].journal interventional radiology,2012,(02):136.
[2]赵玉峰,孙玉琴,韩晓静,等. 输卵管介入再通术后受孕时机的研究[J].介入放射学杂志,2012,(02):158.
ZHAO Yu-feng,SUN Yu-qin,HAN Xiao-jing,et al.The optimal time for conception after fallopian tube recanalization therapy[J].journal interventional radiology,2012,(02):158.
[3]张海潇,顾俊鹏,迪里木拉提·巴吾冬,等.下肢缺血性疾病介入治疗的临床疗效分析[J].介入放射学杂志,2012,(02):111.
ZHANG Hai-xiao,GU Jun-peng,BAWUDUN·Dilmurat,et al.Interventional therapy of lower limb ischemic diseases: a clinical therapeutic analysis[J].journal interventional radiology,2012,(02):111.
[4]何乾文,何远忠,罗来华,等.自制简易碘油推送器[J].介入放射学杂志,2000,(03):134.
[5]黄求理,宋侃侃,吴安乐,等.急性肢体动脉闭塞的血管内介入治疗[J].介入放射学杂志,2000,(03):155.
[6]陈伟敏,付晶,张树华,等.大剂量醛氢叶酸与5-氟尿嘧啶介入治疗晚期胃肠道癌[J].介入放射学杂志,2000,(03):181.
[7]郭添胜,姜在波,黄明声,等.原发性肝癌合并糖尿病介入治疗的围手术期处理[J].介入放射学杂志,2000,(03):182.
[8]张根山,周胜利,张旭.原发性肝癌合并脾功能亢进的介入治疗[J].介入放射学杂志,2000,(03):183.
[9]高爱荣,孙丰敏.血管内栓塞治疗脑动静脉畸形的护理[J].介入放射学杂志,2000,(03):138.
[10]王兴华,朱汉洲,李立.腹部手术后消化道出血的介入诊断与治疗[J].介入放射学杂志,2000,(04):240.